DDX41 and rheumatoid arthritis: To confirm this speculation, a large-scale clinical study in RA patients is necessary to examine the correlations between the clinical efficacy of IFX and various factors, including the trough serum IFX level, anti-IFX antibody, and autoantibodies (including ANAs and anti-ds-DNA Abs).